New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2013
10:02 EDTGTAT, EXC, ALDW, MHK, JNPR, BIO, CBS, RIO, MCY, INFN, ADTN, AIZ, TAL, PKI, MDTOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Adtran (ADTN) upgraded to Neutral from Sell at Citigroup... Bio-Rad (BIO) upgraded to Outperform from Underperform at CLSA... GT Advanced (GTAT) upgraded to Hold from Underperform at Jefferies... Infinera (INFN) upgraded to Overweight from Neutral at JPMorgan... Juniper (JNPR) upgraded to Overweight from Neutral at JPMorgan... Medtronic (MDT) upgraded to Outperform from Neutral at Credit Suisse... Mercury General (MCY) upgraded to Outperform from Neutral at Macquarie... Mohawk (MHK) upgraded to Outperform from Underperform at Macquarie... PerkinElmer (PKI) upgraded to Buy from Outperform at CLSA... Rio Tinto (RIO) upgraded to Buy from Neutral at Citigroup... Alon USA Partners (ALDW) upgraded to Outperform from Neutral at Credit Suisse... TAL International (TAL) upgraded to Buy from Neutral at BofA/Merrill... CBS (CBS) upgraded to Outperform from Neutral at Wedbush... Exelon (EXC) upgraded to Overweight from Equal Weight at Morgan Stanley... Assurant (AIZ) upgraded to Market Perform from Underperform at Raymond James.
News For ADTN;BIO;GTAT;INFN;JNPR;MDT;MCY;MHK;PKI;RIO;ALDW;TAL;CBS;EXC;AIZ From The Last 14 Days
Check below for free stories on ADTN;BIO;GTAT;INFN;JNPR;MDT;MCY;MHK;PKI;RIO;ALDW;TAL;CBS;EXC;AIZ the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
April 14, 2014
10:51 EDTMDTEdwards up after court limits sale of Medtronic's CoreValve in U.S.
Subscribe for More Information
10:02 EDTMDTOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:00 EDTMDTMedtronic falls 5.4%
Medtronic is down 5.4%, or $3.20, to $56.00
08:59 EDTMDTOn The Fly: Pre-market Movers
Subscribe for More Information
07:39 EDTMDTEdwards Lifesciences upgraded to Buy from Fair Value at CRT Capital
Subscribe for More Information
06:22 EDTMDTMedtronic downgraded to Neutral from Overweight at JPMorgan
Subscribe for More Information
06:21 EDTMDTEdwards Lifesciences upgraded to Neutral from Underweight at JPMorgan
Subscribe for More Information
April 13, 2014
15:10 EDTMDTMedtronic says CoreValve ruling has no impact outside U.S.
Subscribe for More Information
April 12, 2014
19:50 EDTMDTEdwards says court limits sale of Medtronic CoreValve system in U.S.
Edwards Lifesciences (EW) announced that the U.S. District Court for the District of Delaware granted a preliminary injunction limiting the sale of Medtronic's (MDT) CoreValve system in the United States. The court ordered the injunction to go into effect in seven business days. The hearing related to a federal jury decision in 2010 that CoreValve willfully infringes Edwards' U.S. Andersen transcatheter aortic valve replacement patent. At the conclusion of the hearing, Chief Judge Gregory Sleet ordered Edwards and Medtronic to confer on what instances the CoreValve device could continue to be used in the treatment of U.S. patients at centers currently trained on CoreValve. There is a large body of evidence demonstrating the safety and performance of the Edwards SAPIEN valves, and the company remains committed to ensuring patients have appropriate access to transcatheter therapy. This case was initiated by Edwards in 2008. On April 1, 2010, a federal jury found Medtronic willfully infringed Edwards' U.S. Andersen patent and awarded damages. In Nov. 2012, the U.S. Court of Appeals for the Federal Circuit affirmed the jury decision; in Oct. 2013, the U.S. Supreme Court declined to hear Medtronic's appeal. The patent involved in this suit is part of the Andersen family of patents. The U.S. Andersen patent was issued in 1995. A petition has been filed with the U.S. Patent and Trademark Office to extend this patent into early 2016. In a separate case, a federal jury in January found that Medtronic CoreValve had willfully infringed Edwards' U.S. Cribier transcatheter heart valve patent, and awarded damages to Edwards in that trial.
April 11, 2014
12:42 EDTJNPROn The Fly: Analyst Initiation Summary
ASML (ASML) initiated with a Cautious at ISI Group... Analog Devices (ADI) initiated with a Buy at ISI Group... Applied Materials (AMAT) initiated with a Strong Buy at ISI Group... Aruba Networks (ARUN) initiated with a Buy at SunTrust... Broadcom (BRCM) initiated with a Neutral at ISI Group... CSX (CSX) initiated with an Outperform at Macquarie... Cisco (CSCO) initiated with a Buy at SunTrust... F5 Networks (FFIV) initiated with a Neutral at SunTrust... Genesee & Wyoming (GWR) initiated with a Neutral at Macquarie... Intel (INTC) initiated with a Neutral at ISI Group... Juniper (JNPR) initiated with a Buy at SunTrust... KLA-Tencor (KLAC) initiated with a Neutral at ISI Group... Lam Research (LRCX) initiated with a Strong Buy at ISI Group... Linear Technology (LLTC) initiated with a Cautious at ISI Group... Maxim Integrated (MXIM) initiated with a Neutral at ISI Group... Micron (MU) initiated with a Strong Buy at ISI Group... NVIDIA (NVDA) initiated with a Neutral at ISI Group... NXP Semiconductors (NXPI) initiated with a Strong Buy at ISI Group... Qualcomm (QCOM) initiated with a Strong Buy at ISI Group... Riverbed (RVBD) initiated with a Neutral at SunTrust... SanDisk (SNDK) initiated with a Neutral at ISI Group... Teradyne (TER) initiated with a Buy at ISI Group... Texas Instruments (TXN) initiated with a Neutral at ISI Group... Trulia (TRLA) initiated with a Neutral at Susquehanna... Union Pacific (UNP) initiated with a Neutral at Macquarie... Zillow (Z) initiated with a Positive at Susquehanna... Flamel Technologies (FLML) initiated with a Buy at Roth Capital... Parker Drilling (PKD) initiated with an Accumulate at Tudor Pickering.
10:59 EDTCBSOptions with increasing implied volatility: EXPE PBI CROX CBS ADSK
Subscribe for More Information
07:29 EDTJNPRNetwork security Q1 survey shows 'respectable' demand, says Jefferies
Subscribe for More Information
06:08 EDTJNPRJuniper initiated with a Buy at SunTrust
Subscribe for More Information
05:59 EDTJNPRJuniper publishes 'High Alert' notice on security home page
Subscribe for More Information
05:57 EDTJNPRCisco, Juniper say some products affected by Heartbleed bug, WSJ reports
Both Cisco (CSCO) and Juniper (JNPR) have disclosed that some of their products are affected by the Heartbleed bug, the Wall Street Journal reports. The companies say the security flaw affects routers, switches and firewalls used by businesses. Reference Link
April 10, 2014
20:03 EDTBIOBio-Rad acquires GnuBIO, terms undisclosed
Bio-Rad Laboratories announced that it has purchased GnuBIO. GnuBIO is developing a faster and fully integrated droplet-based DNA sequencing technology that incorporates all the functions of DNA sequencing into a single, integrated workflow for medical diagnostics as well as research markets.
19:10 EDTMDTMedtronic confirms FDA approval for expanded indications
Subscribe for More Information
16:32 EDTMDTMedtronic gets FDA approval for revised labeling application
The U.S. FDA approved an application from Medtronic for revised labeling for two cardiac resynchronization pacemakers and eight cardiac resynchronization defibrillators, expanding the indication for use to patients with atrioventricular block and less severe heart failure. The FDA previously approved these devices for patients with more severe heart failure as evaluated by their physician using specific criteria. The new approved use includes patients with less severe heart failure, but who are already indicated to receive RV pacing. With the new indication, these patients will be eligible to receive a device that will pace both sides of their heart instead of just the right. Reference Link
12:03 EDTCBSCBS says Stephen Colbert to be next 'Late Show' host
Subscribe for More Information
08:45 EDTJNPRPalo Alto upgraded at JMP Securities
As noted earlier, JMP Securities upgraded Palo Alto (PANW) to Outperform from Market Perform. The firm expects the company to benefit from the strength of its Advanced Persistent Threat service and strong demand for next generation firewall technology. JMP Securities also believes that the company's sales are tracking at least in-line with expectations this quarter, and is more confident that it will prevail in its court battle with Juniper (JNPR). Target $80.
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use